Kolosov, Nikita https://orcid.org/0000-0002-2139-6775
Reeve, Mary P.
Briotta Parolo, Pietro Della
Kurki, Mitja I.
,
Della Briotta Parolo, Pietro
Llorens, Vincent
Sipila, Timo Petteri https://orcid.org/0000-0001-6739-1606
Herman, Adam
Molotkov, Ivan
Aavikko, Mervi https://orcid.org/0000-0003-2583-0150
Ripatti, Samuli https://orcid.org/0000-0002-0504-1202
Palotie, Aarno https://orcid.org/0000-0002-2527-5874
Daly, Mark J. https://orcid.org/0000-0002-0949-8752
Artomov, Mykyta https://orcid.org/0000-0001-5282-8764
Funding for this research was provided by:
Aging Biology Foundation
Article History
Received: 15 September 2025
Accepted: 4 June 2026
First Online: 20 June 2026
Competing interests
: A provisional patent has been filed with respect to the findings described in this manuscript (USPTO serial no. 63/716,306). Mark J. Daly is a founder of Maze Therapeutics. The remaining authors declare no competing interests.